首页> 外国专利> METHODS FOR USING ADAMTS-12, AN INTEGRIN AND METALLOPROTEASE WITH THROMBOSPONDIN MOTIFS

METHODS FOR USING ADAMTS-12, AN INTEGRIN AND METALLOPROTEASE WITH THROMBOSPONDIN MOTIFS

机译:ADAMTS-12,一种整合素和金属蛋白酶与凝血酶配体一起使用的方法

摘要

The present invention relates to methods for using a human A Disintegrin And Metalloprotease containing ThromboSpondin repeats (ADAM-TS). The invention also relates to methods for using polynucleotides encoding the metalloprotease. The invention relates to methods using the ADAM-TS polypeptides and polynucleotides as a target for diagnosis and treatment in metalloprotease-mediated or -related disorders. The invention further relates to drug-screening methods using the ADAM-TS polypeptides and polynucleotides to identify agonists and antagonists for diagnosis and treatment. The invention further encompasses agonists and antagonists based on the ADAM-TS polypeptides and polynucleotides. The invention further relates to agonists and antagonists identified by drug screening methods with the ADAM-TS polypeptides and polynucleotides as a target. The invention further related to methods of treating a subject suffering from a ADAM-TS associated disorder.
机译:本发明涉及使用含有人血红蛋白桥连蛋白重复序列​​(ADAM-TS)的人A整联蛋白和金属蛋白酶的方法。本发明还涉及使用编码金属蛋白酶的多核苷酸的方法。本发明涉及使用ADAM-TS多肽和多核苷酸作为靶标用于金属蛋白酶介导的或相关疾病的诊断和治疗的方法。本发明进一步涉及使用ADAM-TS多肽和多核苷酸来鉴定用于诊断和治疗的激动剂和拮抗剂的药物筛选方法。本发明进一步包括基于ADAM-TS多肽和多核苷酸的激动剂和拮抗剂。本发明进一步涉及通过药物筛选方法以ADAM-TS多肽和多核苷酸为靶标鉴定的激动剂和拮抗剂。本发明进一步涉及治疗患有ADAM-TS相关疾病的受试者的方法。

著录项

  • 公开/公告号EP1531716A4

    专利类型

  • 公开/公告日2007-06-20

    原文格式PDF

  • 申请/专利权人 ATHERSYS INC.;

    申请/专利号EP20030734487

  • 申请日2003-06-06

  • 分类号G01N33/50;G01N33/53;A61B;A61K38;A61K39/395;A61K45;A61P9;A61P9/10;A61P19/02;A61P29;A61P35;A61P43;C07H21/04;C12N9/64;C12N15;C12N15/09;C12Q1;C12Q1/02;C12Q1/37;C12Q1/68;G01N33/573;G01N33/574;

  • 国家 EP

  • 入库时间 2022-08-21 20:48:52

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号